LW402

· Shanghai Longwood Biopharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for LW402, covering 2025-10-02 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Multiple Ascending Dose Study of LW402 in Healthy Volunteers [Phase 1]